Evidence map›Paper›PMID 41356261›Full record

ArticleOncology reviews2025

Structural recurrence in well-differentiated papillary thyroid carcinoma: a 10-year single center cohort study.

Francisco Araújo Dias, Rafael Pereira de Souza, Tabata Briaunys Milan, Rafael De Cicco

Abstract read
In one paragraph

Article in Oncology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francisco Araújo DiasHead and Neck Department - Instituto de Cancer Dr. Arnaldo, São Paulo, Brazil.
Rafael Pereira de SouzaHead and Neck Department - Instituto de Cancer Dr. Arnaldo, São Paulo, Brazil.
Tabata Briaunys MilanHead and Neck Department - Instituto de Cancer Dr. Arnaldo, São Paulo, Brazil.
Rafael De CiccoHead and Neck Department - Instituto de Cancer Dr. Arnaldo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Well-differentiated papillary thyroid carcinoma (PTC) generally carries an excellent prognosis; however, certain pathological features such as gross extrathyroidal extension and tumor diameter ≥2 cm have been associated with structural disease recurrence. This study aimed to identify the key clinical and histopathological factors associated with disease-free survival in patients undergoing total thyroidectomy for PTC. Methods: A retrospective cohort study was conducted including 750 patients who underwent total thyroidectomy with or without neck dissection between 2014 and 2024 at a tertiary academic cancer center. Clinical, pathological, and oncological follow-up data were analyzed over a maximum follow-up period of 100 months. Kaplan-Meier survival analysis, log-rank testing, and Cox proportional hazards regression were employed for statistical evaluation. Results: The structural recurrence rate was 4%, and overall survival reached 99%. In the multivariate analysis, only gross extrathyroidal extension (HR 3.29; p = 0.008) and tumor diameter (HR 1.32; p = 0.013) were independently associated with recurrence. Variables such as age, smoking status, perineural invasion, vascular invasion, and central lymph node involvement did not show significant associations with structural recurrence. Conclusion: Gross extrathyroidal extension and increased tumor diameter were identified as the primary prognostic factors for structural recurrence in patients with PTC. Multicenter studies are warranted to validate these findings in the broader Brazilian population.

Indexed as

cancer recurrencedifferentiated thyroid cancerdisease-free survivalextrathyroid extensionpapillary thyroid carcinomastructural recurrencethyroidectomythyroid neoplasms

Identifiers

PMID41356261
PMCPMC12675403

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.